A detailed history of Trustcore Financial Services, LLC transactions in Cyclerion Therapeutics, Inc. stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 292,645 shares of CYCN stock, worth $512,128. This represents 0.02% of its overall portfolio holdings.

Number of Shares
292,645
Previous 292,645 -0.0%
Holding current value
$512,128
Previous $252,000 23.41%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

BUY
$0.96 - $1.78 $90,757 - $168,279
94,539 Added 47.72%
292,645 $325,000
Q4 2019

Jan 30, 2020

BUY
$1.8 - $13.43 $351,190 - $2.62 Million
195,106 Added 6503.53%
198,106 $539,000
Q2 2019

Jul 25, 2019

BUY
$9.6 - $22.85 $28,800 - $68,550
3,000 New
3,000 $34,000

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0

About Cyclerion Therapeutics, Inc.


  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $76.1M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.